An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Learn More
Pain or numbness in lower back when standing
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Learn MoreAdvanced Practice Providers (#APPs): Ready to take your provider-patient communication to the next level? Be sure to view, “Creating your Mild Talk Track: 3 Simple Steps APPs can take today to enhance Patient Education.” The recent blog featuring APP @acomer3 includes step-by-step guidance on how you can use the Mild Patient Brochure most effectively, peer-led video demonstrations, and additional tips & resources to help facilitate your consultations.
Help your lumbar spinal stenosis (#LSS) patients understand their condition and get on the path to lasting relief.
View blog at #linkinbio.
Extensive evidence, clear consensus! MIST 2.0 has recently been published in the Journal of Pain Research.
Based on over 150 evidence sources, the @aspn_painneuro created guidance for best practices for minimally invasive surgical treatment of symptomatic spinal stenosis.
This society-sponsored publication concluded that the Mild Procedure received the highest quality of evidence and certainty of net benefit.
Additionally MIST 2.0 put Mild ahead of other interventional therapies recommending Mild as an early, first-line therapy for lumbar spinal stenosis (#LSS) after conservative therapy fails.
Click the #linkinbio to read the full publication.
Follow the data! The Pain Medicine journal recently published the Level 1 MOTION Study 1-year results highlighting the superiority of the Mild Procedure in combination with conventional medical management (CMM) over the use of CMM alone for patients with lumbar spinal stenosis (#LSS) suffering from neurogenic claudication (NC).
Review the complete findings and hear principal investigator, Dr. @timdeer30a, discuss why Mild is effective as an early interventional therapy for LSS at the #linkinbio.
We know that Advanced Practice Providers (APPs) are committed to going above and beyond to bring effective relief to lumbar spinal stenosis (#LSS) patients. That is why we’re committed to making sure you have all the resources and support you need to identify and educate patients about the Mild Procedure.
Visit our blog at the #linkinbio to access our growing library of case studies, educational webinars, and peer insights.
To stay connected to the latest events and opportunities, join our Mild Network by connecting with us online at mildAPP.com.
Physicians and Advanced Practice Providers (APPs) have the clinical and technical experience with the Mild Procedure, but how often do they have the opportunity to watch the functional improvement in as close a setting as their own family? @acomer3 shares her grandmother's experience with the Mild Procedure.
Help your lumbar spinal stenosis (#LSS) get on the path to lasting relief by making the #MOVE2mild earlier in your treatment algorithm.
Mild made a major impact during the @aspn_painneuro Annual Conference in Miami! We couldn’t have done it without the leadership of so many outstanding Physicians and Advanced Practice Providers (APPs) who are helping make the Mild Procedure the gold standard of care for lumbar spinal stenosis (#LSS) patients.
More thanks to the spectacular group of proctors who spent the day coaching HUNDREDS of physicians on Mild Procedure best practices and procedural techniques, it’s so exciting to be a part of the biggest hands-on training opportunity in the interventional spine specialty!
We're honored to have been a part of this premier meeting full of cutting-edge research and scientific advancement, and we’re looking forward to seeing this group again in December at the upcoming Innovation Summit.
Miami got moving! Thank you to the physicians, Advanced Practice Providers (APPs), and patients who joined us for our National Health Awareness Campaign “Know Your Back Story” and made our final tour stop at the @aspn_painneuro 2022 Conference so successful.
We are so grateful for everyone who has joined us for all our tour stops and got moving with us. Thank you for helping empower patients and providers to rewrite more “back stories” and get lumbar spinal stenosis (#LSS) patients back on their feet. Let’s get moving!
West Palm Beach welcomed the Know Your Back Story National Health Awareness Tour. Through interactive exhibits and patient testimonials, we’re helping more physicians, Advanced Practice Providers (APPs), and patients make the connection between an enlarged ligament and low back pain.
Thank you for joining us to learn more about rewriting your lumbar spinal stenosis (#LSS) patient’s “back story.” Let’s get moving!
@pain4eemd
@stangolovac
@apmwellness
Why is Mild the preferred first-line therapy for lumbar spinal stenosis (#LSS) patients? Extensive evidence demonstrates that the Mild Procedure is the only treatment with a safety profile equivalent to an injection and the lasting relief expected from back surgery.*
Clinical evidence demonstrates there is no benefit to giving more than one epidural steroid injection (ESI) before the Mild Procedure. In fact, the authors of a recent study concluded that participants treated with 0-1 ESIs before receiving Mild and participants treated with 2 or more ESIs saw no significant difference in pain reduction.*
Make the #MOVE2mild and put your patients on the path to lasting relief.
*View clinical data at the #linkinbio.
How can you use Level 1 Data to enhance patient confidence? Dr. @dsayed123 proactively discusses the results of the MOTION multicenter randomized controlled trial during Mild patient consultations. He says, "when I can confidently counsel my patients about the real-world results of the Mild Procedure data it instantly puts them at ease.”
See the MOTION data to make the #MOVE2mild earlier in your treatment algorithm and put more patients on the path to lasting relief at the #linkinbio.
Tour dates in the Sunshine State are on a roll! In Sarasota, physicians, Advanced Practice Providers (APPs), and patients joined us to learn more about the connection between an enlarged ligament and low back pain.
Thank you for joining us in our mission to help more lumbar spinal stenosis (#LSS) patients rewrite their “back story.”
@_dr.azeem
@lindsayandmolly
Mayor @erikthefirst
City Vice Mayor @kswbattie
County Commissioner @moransarasota
Welcome to Team Vertos! We are excited to have new members joining us in our mission to offer safe, effective solutions to the lumbar spinal stenosis (#LSS) community.
Joining Team Vertos are our new District Sales Managers, Jeremiah Ubben, Tom Best, and Jeff Orr, District Sales Specialist, Suzi Ruggles, Clinical Training Coordinator, Kevin Nguyen, Clinical Training Specialist, Steven Cefalu, and Employee Experience & Events Coordinator, Megan Vallely.
Interested in joining our team? Click the #linkinbio for employment opportunities.
Join us for some fun in the Sunshine State!
Mark your calendars for an interactive educational experience that can help people in your community learn more about how an enlarged ligament could be the cause of their low back and leg pain.
Join us with your colleagues, Advanced Practice Providers (APPs), staff, and patients to help patients rewrite their “back stories” and get on the path to lasting relief.
July 7 - Sarasota, FL
July 13 - West Palm Beach, FL
July 15-16 - Miami, FL
Visit KnowYourBackStory.com or the #linkinbio for locations and times.
What are you waiting for? Let's Get Moving!
Washington DC got moving! Thank you to all the physicians, Advanced Practice Providers (APPs), and patients who joined us to learn more about the connection between an enlarged ligament and low back pain on our National Health Awareness Campaign tour.
We are excited to be able to help more lumbar spinal stenosis (#LSS) patients rewrite their “back story” and step with strength, confidence, and enthusiasm into their next exciting chapter. Let’s get moving!
Visit www.KnowYourBackStory.com or the #linkinbio for upcoming tour stops and to learn more.
Philadelphia showed us lots of love! Thank you to all the physicians, Advanced Practice Providers (APPs), and patients that joined us and made the Philly tour stop of the National Health Awareness Campaign so successful!
We are so grateful for the opportunity to empower more lumbar spinal stenosis (#LSS) patients and those suffering from an enlarged ligament to learn more about their “back story."
@doctorjoedo
@sanjayshahmd
@stangolovac
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’ Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
